Keywords: Antivirals, Charity programs, AIDS Healthcare Foundation, AHF, Gilead, Boehringer Ingelheim, Tax breaks

AIDS drugmakers’ charity programs fail patients, yet provide millions in tax breaks to industry, AHF accuses, but applauds Boehringer

Article | 03 August 2011

Print This

The USA-based AIDS Healthcare Foundation (AHF) is, in its own words, “blowing the whistle” on a little known, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in